Cannabis & CBD Genetics from 23andMe or AncestryDNA Data (2026)
5 min read · Last reviewed: April 2026 · DecodeMyBio Editorial Team
If you have ever wondered why cannabis affects you differently than the people around you — stronger highs, longer-lasting effects, unexpected side effects from CBD — the answer may be in the DNA data you have already uploaded. Your 23andMe or AncestryDNA raw file contains the exact genetic variants that determine how your body metabolizes THC and CBD.
What Your DNA Data Already Contains
Consumer DNA chips from 23andMe, AncestryDNA, MyHeritage, and FamilyTreeDNA test hundreds of thousands of genetic positions. Among them are the key variants in four cannabis-relevant enzymes:
- CYP2C9 — handles approximately 70% of THC clearance. Variants in this gene can cause up to 3x higher THC exposure.
- CYP2C19 — the primary enzyme for CBD 7-hydroxylation. Your metabolizer status affects CBD-to-metabolite ratios and efficacy.
- CYP3A5 — when combined with CYP2C19, a specific genotype combination increases CBD side effect risk by 5.6x (gastrointestinal effects).
- CYP1A2 — induced by smoked (not vaped) cannabis through combustion byproducts. Affects caffeine, clozapine, and other medication levels.
Why THC Affects You Differently
The most significant genetic factor is CYP2C9. People with the *3 variant clear THC up to 3 times more slowly than those with normal enzyme function. In practice, this means:
- The same dose produces a stronger, longer-lasting high
- THC stays in your system longer (relevant for drug testing)
- You may be more prone to negative effects like anxiety or paranoia
About 15-20% of people of European descent carry at least one reduced-function CYP2C9 allele. These variants determine your metabolizer status — the same framework used for prescription drug metabolism.
Why CBD Causes Side Effects for Some People
A 2026 clinical study found that people with a specific combination of CYP3A5 poor metabolizer + CYP2C19 intermediate/normal metabolizer genotypes experienced CBD-related diarrhea at a rate of 39%, compared to just 7% in other genotype combinations. This 5.6-fold difference is driven by a metabolic shunting effect: when CYP3A5 is reduced, more CBD goes through the CYP2C19 pathway, producing excess active metabolite.
If CBD has given you GI issues, this gene-gene interaction may be the reason.
How to Get Your Cannabis Genetics Report
DecodeMyBio's Cannabis & CBD Report analyzes all four genes from your existing raw data — no new sample needed. The report covers THC metabolism, CBD processing, the CYP3A5+CYP2C19 side effect interaction, and smoked cannabis drug interactions. It costs $29 and produces results in minutes.
You can also preview a sample Cannabis & CBD Report to see the format before purchasing.
What the Report Does Not Cover
This report does not predict subjective experience (euphoria vs. anxiety), cannabis dependence risk, or tolerance effects. It does not recommend strains, products, or dosing. It is educational only and does not endorse cannabis use. Cannabis laws vary by jurisdiction.